IL140731A0 - Antimicrobial compounds, pharmaceutical compositions containing the same and methods for the preparation thereof - Google Patents

Antimicrobial compounds, pharmaceutical compositions containing the same and methods for the preparation thereof

Info

Publication number
IL140731A0
IL140731A0 IL14073199A IL14073199A IL140731A0 IL 140731 A0 IL140731 A0 IL 140731A0 IL 14073199 A IL14073199 A IL 14073199A IL 14073199 A IL14073199 A IL 14073199A IL 140731 A0 IL140731 A0 IL 140731A0
Authority
IL
Israel
Prior art keywords
preparation
methods
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL14073199A
Other languages
English (en)
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of IL140731A0 publication Critical patent/IL140731A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/167Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • C12P19/40Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
IL14073199A 1998-07-09 1999-07-09 Antimicrobial compounds, pharmaceutical compositions containing the same and methods for the preparation thereof IL140731A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19428598 1998-07-09
JP26944598 1998-09-24
PCT/JP1999/003718 WO2000002892A1 (fr) 1998-07-09 1999-07-09 Nouveaux composes antibacteriens

Publications (1)

Publication Number Publication Date
IL140731A0 true IL140731A0 (en) 2002-02-10

Family

ID=26508414

Family Applications (3)

Application Number Title Priority Date Filing Date
IL14073199A IL140731A0 (en) 1998-07-09 1999-07-09 Antimicrobial compounds, pharmaceutical compositions containing the same and methods for the preparation thereof
IL140731A IL140731A (en) 1998-07-09 2001-01-04 History of capuramycin antimicrobials and pharmaceutical preparations containing them
IL187551A IL187551A (en) 1998-07-09 2007-11-22 Antimicrobial capuramycin derivatives and pharmaceutical compositions containing the same

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL140731A IL140731A (en) 1998-07-09 2001-01-04 History of capuramycin antimicrobials and pharmaceutical preparations containing them
IL187551A IL187551A (en) 1998-07-09 2007-11-22 Antimicrobial capuramycin derivatives and pharmaceutical compositions containing the same

Country Status (23)

Country Link
US (2) US6472384B1 (fr)
EP (3) EP1319666B1 (fr)
KR (2) KR100622889B1 (fr)
CN (1) CN1181087C (fr)
AT (2) ATE356825T1 (fr)
AU (1) AU751470B2 (fr)
BR (1) BR9911965A (fr)
CA (1) CA2337225C (fr)
DE (2) DE69927306T2 (fr)
DK (2) DK1095947T3 (fr)
ES (2) ES2284260T3 (fr)
HK (2) HK1053127B (fr)
HU (1) HUP0103711A3 (fr)
ID (1) ID27955A (fr)
IL (3) IL140731A0 (fr)
NO (1) NO322083B1 (fr)
NZ (1) NZ509233A (fr)
PL (1) PL200426B1 (fr)
PT (1) PT1095947E (fr)
RU (1) RU2209210C2 (fr)
TR (1) TR200100059T2 (fr)
WO (1) WO2000002892A1 (fr)
ZA (1) ZA200100200B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
EP1322504A1 (fr) 2000-09-25 2003-07-02 Volkswagen AG Dispositif d'airbag et son procede de fonctionnement
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
CN101404986B (zh) * 2002-05-17 2011-09-28 赛奎拉公司 用于诊断和治疗感染性疾病的组合物和制药方法
WO2005034857A2 (fr) * 2003-09-05 2005-04-21 Sequella, Inc. Procedes et compositions renfermant des diamines comme nouveaux produits therapeutiques antituberculeux
EP1771435A4 (fr) * 2004-06-19 2008-02-13 Human Biomolecular Res Inst Modulateurs de neurotransmetteurs du systeme nerveux central
US20090068325A1 (en) * 2007-09-10 2009-03-12 Gil Depicciotto Method of treatment of fresh produce
WO2009136965A1 (fr) * 2008-05-06 2009-11-12 Sequella, Inc. Compositions et procédés comprenant des analogues de la capuramycine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60259190A (ja) * 1984-06-06 1985-12-21 Kanto Ishi Pharma Co Ltd 新抗生物質カプラマイシン及びその製造法
US5034381A (en) 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
JPH05148293A (ja) * 1991-11-28 1993-06-15 Mect Corp 新規カプラマイシン誘導体およびその製造方法
GB9307043D0 (en) 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
TWI245047B (en) 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives

Also Published As

Publication number Publication date
KR100729196B1 (ko) 2007-06-19
DE69927306D1 (de) 2005-10-20
NO20010105L (no) 2001-03-08
DE69935513T2 (de) 2007-11-29
DK1095947T3 (da) 2007-07-16
DK1319666T3 (da) 2005-12-05
KR20010083101A (ko) 2001-08-31
HK1053127A1 (en) 2003-10-10
DE69935513D1 (de) 2007-04-26
ES2248654T3 (es) 2006-03-16
IL140731A (en) 2008-06-05
WO2000002892A1 (fr) 2000-01-20
EP1095947A1 (fr) 2001-05-02
CA2337225A1 (fr) 2000-01-20
HK1053127B (zh) 2005-12-30
KR100622889B1 (ko) 2006-09-12
BR9911965A (pt) 2001-05-29
NO322083B1 (no) 2006-08-14
CA2337225C (fr) 2009-05-26
NO20010105D0 (no) 2001-01-08
HUP0103711A2 (hu) 2002-02-28
AU751470B2 (en) 2002-08-15
DE69927306T2 (de) 2006-07-06
EP1319666A1 (fr) 2003-06-18
IL187551A0 (en) 2008-03-20
ATE356825T1 (de) 2007-04-15
ATE304548T1 (de) 2005-09-15
IL187551A (en) 2009-12-24
PT1095947E (pt) 2007-06-20
HK1053063A1 (zh) 2003-10-10
EP1319406A1 (fr) 2003-06-18
US6472384B1 (en) 2002-10-29
RU2209210C2 (ru) 2003-07-27
KR20060011919A (ko) 2006-02-03
US20030069204A1 (en) 2003-04-10
EP1319666B1 (fr) 2005-09-14
AU4650599A (en) 2000-02-01
TR200100059T2 (tr) 2001-05-21
HUP0103711A3 (en) 2003-11-28
US6844173B2 (en) 2005-01-18
ID27955A (id) 2001-05-03
EP1095947B1 (fr) 2007-03-14
EP1095947A4 (fr) 2002-01-16
NZ509233A (en) 2003-05-30
CN1317008A (zh) 2001-10-10
ZA200100200B (en) 2002-06-26
PL345403A1 (en) 2001-12-17
CN1181087C (zh) 2004-12-22
PL200426B1 (pl) 2009-01-30
ES2284260T3 (es) 2007-11-01

Similar Documents

Publication Publication Date Title
IL187551A0 (en) Antimicrobial capuramycin derivatives and pharmaceutical compositions containing the same
YU11699A (sh) 6-supstituisani ketolidi koji imaju antibakterijsko dejstvo, postupci za njihovo dobijanje i njihovi farmaceutski preparati
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
CA2145826A1 (fr) Derives de lipopeptide; methode de preparation et utilisation
MX9803650A (es) Agentes antimicrobianos de benzoxazina.
GEP20094834B (en) Macrolides, pharmaceutical compositions containing them and their use for treatment of bacterial infections
BG103947A (en) Derivatives of 9-oxymerythromycin
BG103292A (en) 6-0-substituted ketolides possessing antibacterial effect
GEP20032896B (en) 4-Aminothiazole Derivatives, Containing Them Pharmaceutical Compositions Inhibiting Cyclin-Dependent Kinases and Methods for Treatment
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
MX9708611A (es) Compuestos de dialquiltiacumicina.
EP0791582A4 (fr) Derives des esters de l'acide indole-2-carboxylique, et bactericides destines a l'agriculture et a l'horticulture contenant ceux-ci comme ingredients actifs
AU2998797A (en) 6-o-substituted erythromycin compounds and method for making same
CA2386685A1 (fr) Utilisation de derives de pleuromutiline pour le traitement transdermique de maladies bacteriennes
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
GEP20032970B (en) Pharmaceutical Compositions of Tizoxanide and Nitazoxanide
AU5390900A (en) Potassium channel blocking agents
WO2000010998A3 (fr) Antibiotique au pyridone a profil d'innocuite ameliore
WO2002018353A3 (fr) Agents chimiotherapeutiques d'oxazolidinone
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
AU2002214197A1 (en) Macrolides
AP2002002494A0 (en) Hygromycin derivatives.
FR2412564A1 (fr) Nouvelles 2' -n-acyl- et alkyl-6' -n-alkyl- et 6', 6' -di-n-alkyl-fortimicines a et b, utiles notamment comme antibiotiques
NZ268476A (en) 14-substituted marcfortines, preparation and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
FF Patent granted